Studies from Denise Wolff et al Have Provided New Data on Atopic Dermatitis (AMCP Market Insights: Beyond skin deep on the role of managed care in moderate to severe atopic dermatitis): Skin Diseases and Conditions – Atopic Dermatitis

2026 MAY 11 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Data detailed on Skin Diseases and Conditions - Atopic Dermatitis have been presented. According to news reporting out of Duluth, Minnesota, by NewsRx editors, research stated, “Atopic dermatitis (AD), is a chronic, relapsing inflammatory skin disorder that can pose a significant burden to patients and their caregivers and decrease their quality of life. Although substantial advances have been made in the safety and effectiveness of treatments for moderate to severe AD, opportunity for improvement remains.”

Our news journalists obtained a quote from the research, “To better understand the patient journey and to consider the management of both current and emerging treatments, AMCP Market Insights virtually convened an expert panel of managed care stakeholders in November 2025. This article provides a qualitative summary of the panel discussion. Key insights include that delayed diagnosis and limited access to dermatology specialists are top gaps in the provision of equitable care in moderate to severe AD and that despite treatment advances, more effective and affordable options are needed. Additionally, treatment adherence and positive outcomes in moderate to severe AD are multifactorial and may be affected by elements such as timely access, care coordination, disease severity and variability, and medication coverage and costs. Emerging agents show promise for a more durable response with less frequent dosing than current therapies, but payers are waiting for additional data to demonstrate long-term safety and efficacy and real-world outcomes.”

According to the news editors, the research concluded: “These findings can support informed clinical and coverage decisions, can offer practical actions for payers, and may inform future work.”

This research has been peer-reviewed.

For more information on this research see: AMCP Market Insights: Beyond skin deep on the role of managed care in moderate to severe atopic dermatitis. Journal of Managed Care & Specialty Pharmacy, 2026;32. Journal of Managed Care & Specialty Pharmacy can be contacted at: Acad Managed Care Pharmacy, 100 N Pitt St, 400, Alexandria, VA 22314-3134, USA.

Our news journalists report that additional information may be obtained by contacting Denise Wolff, Denise & Co. LLC, Duluth, MN. Additional authors for this research include Bridget Flavin, Mike Abdo, Aderonke Adeboye, Mona Chitre, Zachary Contreras, Gaurang Gandhi, Mark Lebwohl, Terry Richardson and Wendy Smith Begolka.

Publisher contact information for the Journal of Managed Care & Specialty Pharmacy is: Acad Managed Care Pharmacy, 100 N Pitt St, 400, Alexandria, VA 22314-3134, USA.

(Our reports deliver fact-based news of research and discoveries from around the world.)